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Dear Editor 
Mouth blistering and ulceration associated with 
inhaled steroids 
Known steroid inhaler related oral manifestations 
include irritation, dryness, candidiasis, and angina 
bullosa haemorrhagica (1,2). The New Zealand 
Centre for Adverse Reaction Monitoring have 
received four reports of stomatitis associated with 
budesonide and beclomethasone inhalation. 
CASE 1 
A g-year-old boy developed vesicles on the under- 
side of the tongue and inside the lips and gums 1 day 
after commencing budesonide aerosol inhaler 400 pug 
twice daily and terbutaline inhaler, 0.25 mg as necess- 
ary, for nocturnal cough. The inhalers were discon- 
tinued. The vesicles sloughed, the ulcers became 
secondarily infected and resembled herpes stomatitis. 
However, fluorescence and viral cultures were nega- 
tive for herpes simplex, vericella and coxsackie 
viruses. 
CASE2 
A 69-year-old female developed blistering and 
ulceration of the mouth and tongue 10 days after 
commencing budesonide, 400 ,ug dry powder 
(‘Turbuhaler’) twice daily by inhalation for wheeze. 
Resolution followed drug withdrawal. 
CASE 3 
A 61-year-old male developed blistering and ulcer- 
ation of the mouth 2 weeks after starting beclometha- 
sone aerosol inhaler, 5OOpg b.d. for asthma. The 
condition resolved on discontinuing the steroid but 
recurred within a few days on each of two subsequent 
reexposures. 
CASE 4 
A 67-year-old woman developed stomatitis and 
swollen lips after using budesonide aerosol inhaler 
400,~~g for asthma. Rechallenge a month later was 
associated with the same reaction, although the 
patient tolerated inhaled beclomethasone without 
ill-effect. 
The temporal relationship, similar pattern of reac- 
tion, improvement on dechallenge, recurrence on 
rechallenge in the two cases, and the fact that three of 
the four patients were on inhaled steroids alone, 
suggest a causal relationship. The World Health 
Organisation Collaborating Centre for International 
Drug Monitoring have received six other notifi- 
cations of stomatitis, including ulcerative stomatitis, 
associated with inhaled budesonide, 33 with inhaler 
beclomethasone, and four with inhaled flunisolide. 
The entity appears to be distinct from other inhaled 
related oral manifestations including angina bullosa 
haemorrhagica, which is characterized by blood 
blisters, typically on the soft palate, after long term 
(more than 5 years) steroid inhaler use where there is 
demonstrable mucosal atrophy (1,2). 
The mechanism of the steroid-related stomatitis 
described here is unknown. Up to 80% of inhaled 
preparations impact into the oral cavity (3) and the 
reaction may be the consequence of a direct irritant 
effect. Buccal ulceration has been rarely described 
with ipratropium bromide (4) and pharnygeal blis- 
tering with combined ipratropium and terbutaline 
(5). Stomatitis has not been described as one of the 
adverse effects of nondrug components of inhalers, 
such as propellants, preservatives and surfactants, 
or of physical factors such as pH and osmolality 
(6). Furthermore, stomatitis was associated with a 
number of different brands in the WHO reports and 
with the aerosol inhaler and dry powder device 
which would tend to limit the possibility of a 
common causal excipient. Although viral studies 
were negative in the one case where they were 
performed it is possible the reaction simply repre- 
sents activation of latent or subclinical viral infec- 
tion in susceptible individuals due to decreased local 
resistance. 
The stomatitis is troublesome but self-limited, and 
regular prescribers of inhaled steroids may have 
encountered the association. Simple measures such as 
spacer devices which reduce the topical dose, and 
mouth rinsing may obviate the need for withdrawal 
of the steroid inhaler. 
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